Shares of Johnson & Johnson
JNJ,
slid 1.02% to $143.87 Monday, on what proved to be an all-around favorable buying and selling session for the stock market, with the S&P 500 Index
SPX,
rising 0.56% to three,577.59 and the Dow Jones Industrial Common
DJIA,
rising 1.12% to 29,591.27. This was the stock’s fifth consecutive day of losses. Johnson & Johnson closed $13.13 under its 52-week excessive ($157.00), which the corporate reached on April 23rd.
The stock demonstrated a blended efficiency when in comparison with a few of its rivals Monday, as Roche Holding AG Half. Cert.
RHHVF,
fell 1.59% to $327.25, Merck & Co. Inc.
MRK,
fell 0.21% to $80.28, and Pfizer Inc.
PFE,
fell 0.49% to $36.52. Buying and selling quantity (7.three M) eclipsed its 50-day common quantity of 6.5 M.
Editor’s Notice: This story was auto-generated by Automated Insights utilizing information from Dow Jones and FactSet. See our market information phrases of use.
